This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

NextGxDx And Athenahealth To Improve Clinicians' Genetic Testing Order Workflow

NASHVILLE, Tenn., Sept. 30, 2013 /PRNewswire/ -- NextGxDx Inc., the most comprehensive online marketplace for genetic testing, yesterday announced that through its work with athenahealth, Inc. (NASDAQ: ATHN), a leading provider of cloud-based services for electronic health record ( EHR), practice management, and care coordination, the companies will deliver an integrated platform to help clinicians more effectively navigate and improve genetic test ordering.

NextGxDx is designed to make the complex process of genetic testing simpler. Empowered by an intuitive user interface, physicians and other health care professionals can access up to date listings of all genetic tests from CLIA certified laboratories, order tests online, and receive results electronically. The company's bioinformatics team uses proprietary tools to update and curate test data.

By making the network of NextGxDx-affiliated labs visible within athenaClinicals, athenahealth's Best in KLAS EHR service, clinicians will have a streamlined genetic testing workflow, as well as a broader ordering network from which to order from.

Mark Harris, PhD, Chief Executive Officer, NextGxDx, who announced the new partnership from the stage of the Health 2.0 conference, said: "We believe in the vision of athenahealth, and both companies were founded on the premise that technology can help solve some of the inefficiencies in healthcare to deliver better results for patients and clinicians. We're honored to join forces with athenahealth to support their suite of solutions and provide their customers with an intuitive clinical interface for genetic testing."

"Genetic testing is becoming increasingly mainstream and more applicable to patient outcomes, but the rate of growth makes it difficult for clinicians to fully utilize these tests. athenahealth is dedicated to providing our customers with innovative healthcare solutions, and in collaborating with NextGxDx, we are thrilled to be the first to provide an integrated tool that will allow our clinicians to find and order the most clinically appropriate products," said Jasmine Gee, Director of Product Marketing, athenahealth.

For more information on NextGxDx, the most comprehensive database of genetic testing products in the U.S., visit its website,, or follow along on Twitter and Facebook.

For more information on athenahealth's full suite of cloud-based services for clinicians, please visit their website,, or follow along on their blog, Twitter, and Facebook.

About NextGxDx, Inc.

NextGxDx, Inc. provides an online genetic testing marketplace that offers healthcare professionals and hospitals the ability to access up to date listings of all genetic tests from CLIA-certified laboratories, view pertinent information about each test, order tests online, and manage results electronically within the HIPAA-compliant portal. By providing clinicians with a one-stop-shop to search, compare and order genetic tests, NextGxDx reduces the time and costs associated with the ordering of genetic tests.  For more information, please visit or call 615-236-4560

About athenahealth, Inc.

athenahealth is a leading provider of cloud-based services for EHR, practice management, and care coordination. athenahealth's mission is to be caregivers' most trusted service, helping them do well doing the right thing. For more information, please visit or call 888-652-8200.


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs